GNG8
gene geneOn this page
Summary
GNG8 (G protein subunit gamma 8, HGNC:19664) is a protein-coding gene on chromosome 19q13.32, encoding Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 (Q9UK08). Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems.
Predicted to enable G-protein beta-subunit binding activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Predicted to act upstream of or within cellular response to pheromone; nose development; and social behavior. Predicted to be located in plasma membrane. Predicted to be part of heterotrimeric G-protein complex.
Source: NCBI Gene 94235 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 13 total
- MANE Select transcript:
NM_033258
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19664 |
| Approved symbol | GNG8 |
| Name | G protein subunit gamma 8 |
| Location | 19q13.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000167414 |
| Ensembl biotype | protein_coding |
| Entrez | 94235 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000300873, ENST00000693335, ENST00000907311, ENST00000938467, ENST00000953504, ENST00000953505, ENST00000953506, ENST00000953507
RefSeq mRNA: 1 — MANE Select: NM_033258
NM_033258
CCDS: CCDS12687
Canonical transcript exons
ENST00000693335 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001112770 | 46634599 | 46634725 |
| ENSE00003924448 | 46633953 | 46634204 |
| ENSE00003937952 | 46636147 | 46636202 |
Expression profiles
Bgee: expression breadth ubiquitous, 155 present calls, max score 93.46.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0506 / max 88.9969, expressed in 330 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181660 | 0.8227 | 314 |
| 181657 | 0.1248 | 38 |
| 181656 | 0.1032 | 31 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 93.46 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 92.81 | gold quality |
| hypothalamus | UBERON:0001898 | 92.52 | gold quality |
| right atrium auricular region | UBERON:0006631 | 91.50 | gold quality |
| popliteal artery | UBERON:0002250 | 90.92 | gold quality |
| tibial artery | UBERON:0007610 | 90.90 | gold quality |
| monocyte | CL:0000576 | 90.77 | gold quality |
| cardiac atrium | UBERON:0002081 | 90.38 | gold quality |
| aorta | UBERON:0000947 | 90.35 | gold quality |
| ascending aorta | UBERON:0001496 | 90.30 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.20 | gold quality |
| thoracic aorta | UBERON:0001515 | 90.03 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 88.43 | gold quality |
| spinal cord | UBERON:0002240 | 88.23 | gold quality |
| leukocyte | CL:0000738 | 88.22 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 87.81 | gold quality |
| right coronary artery | UBERON:0001625 | 87.79 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 87.57 | gold quality |
| amygdala | UBERON:0001876 | 87.20 | gold quality |
| pituitary gland | UBERON:0000007 | 86.90 | gold quality |
| putamen | UBERON:0001874 | 85.79 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 85.38 | gold quality |
| nucleus accumbens | UBERON:0001882 | 84.26 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.93 | gold quality |
| cortical plate | UBERON:0005343 | 83.92 | gold quality |
| left coronary artery | UBERON:0001626 | 83.77 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.21 | gold quality |
| body of uterus | UBERON:0009853 | 82.32 | gold quality |
| substantia nigra | UBERON:0002038 | 81.77 | gold quality |
| coronary artery | UBERON:0001621 | 81.74 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.77 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gng8 | ENSDARG00000042970 |
| mus_musculus | Gng8 | ENSMUSG00000063594 |
| rattus_norvegicus | Gng8 | ENSRNOG00000016701 |
Paralogs (11): GNG11 (ENSG00000127920), GNGT1 (ENSG00000127928), GNG5B (ENSG00000133136), GNG3 (ENSG00000162188), GNGT2 (ENSG00000167083), GNG4 (ENSG00000168243), GNG12 (ENSG00000172380), GNG5 (ENSG00000174021), GNG7 (ENSG00000176533), GNG2 (ENSG00000186469), GNG10 (ENSG00000242616)
Protein
Protein identifiers
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 — Q9UK08 (reviewed: Q9UK08)
Alternative names: Gamma-9
All UniProt accessions (1): Q9UK08
UniProt curated annotations — full annotation on UniProt →
Function. Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.
Subunit / interactions. G proteins are composed of 3 units, alpha, beta and gamma.
Subcellular location. Cell membrane.
Similarity. Belongs to the G protein gamma family.
RefSeq proteins (1): NP_150283* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001770 | G-protein_gamma | Family |
| IPR015898 | G-protein_gamma-like_dom | Domain |
| IPR036284 | GGL_sf | Homologous_superfamily |
Pfam: PF00631
UniProt features (4 total): chain 1, propeptide 1, modified residue 1, lipid moiety-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UK08-F1 | 90.02 | 0.73 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 67, 67
Function
Pathways and Gene Ontology
Reactome pathways
29 pathways
| ID | Pathway |
|---|---|
| R-HSA-1296041 | Activation of G protein gated Potassium channels |
| R-HSA-163359 | Glucagon signaling in metabolic regulation |
| R-HSA-202040 | G-protein activation |
| R-HSA-381676 | Glucagon-like Peptide-1 (GLP1) regulates insulin secretion |
| R-HSA-392170 | ADP signalling through P2Y purinoceptor 12 |
| R-HSA-392451 | G beta:gamma signalling through PI3Kgamma |
| R-HSA-392851 | Prostacyclin signalling through prostacyclin receptor |
| R-HSA-400042 | Adrenaline,noradrenaline inhibits insulin secretion |
| R-HSA-4086398 | Ca2+ pathway |
| R-HSA-416476 | G alpha (q) signalling events |
| R-HSA-416482 | G alpha (12/13) signalling events |
| R-HSA-418217 | G beta:gamma signalling through PLC beta |
| R-HSA-418555 | G alpha (s) signalling events |
| R-HSA-418592 | ADP signalling through P2Y purinoceptor 1 |
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-418597 | G alpha (z) signalling events |
| R-HSA-420092 | Glucagon-type ligand receptors |
| R-HSA-428930 | Thromboxane signalling through TP receptor |
| R-HSA-432040 | Vasopressin regulates renal water homeostasis via Aquaporins |
| R-HSA-456926 | Thrombin signalling through proteinase activated receptors (PARs) |
| R-HSA-500657 | Presynaptic function of Kainate receptors |
| R-HSA-6814122 | Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding |
| R-HSA-8964315 | G beta:gamma signalling through BTK |
| R-HSA-8964616 | G beta:gamma signalling through CDC42 |
| R-HSA-9009391 | Extra-nuclear estrogen signaling |
| R-HSA-9634597 | GPER1 signaling |
| R-HSA-9660821 | ADORA2B mediated anti-inflammatory cytokines production |
| R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells |
| R-HSA-997272 | Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
MSigDB gene sets: 146 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS, MYOGENIN_Q6, GOBP_BEHAVIOR, REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION, NKX25_02, REACTOME_POTASSIUM_CHANNELS, REACTOME_INWARDLY_RECTIFYING_K_CHANNELS, REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION, REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS, GCANCTGNY_MYOD_Q6, AREB6_03, REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION, CAGCTG_AP4_Q5, GOBP_NOSE_DEVELOPMENT
GO Biological Process (6): G protein-coupled receptor signaling pathway (GO:0007186), nervous system development (GO:0007399), social behavior (GO:0035176), nose development (GO:0043584), cellular response to pheromone (GO:0071444), signal transduction (GO:0007165)
GO Molecular Function (3): GTPase activity (GO:0003924), G-protein beta-subunit binding (GO:0031681), protein binding (GO:0005515)
GO Cellular Component (3): heterotrimeric G-protein complex (GO:0005834), plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-12 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 5 |
| Signal amplification | 3 |
| Regulation of insulin secretion | 2 |
| G-protein beta:gamma signalling | 2 |
| G protein gated Potassium channels | 1 |
| Integration of energy metabolism | 1 |
| Opioid Signalling | 1 |
| Platelet homeostasis | 1 |
| Beta-catenin independent WNT signaling | 1 |
| Class B/2 (Secretin family receptors) | 1 |
| Aquaporin-mediated transport | 1 |
| Platelet activation, signaling and aggregation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| system development | 1 |
| behavior | 1 |
| biological process involved in intraspecies interaction between organisms | 1 |
| sensory organ development | 1 |
| respiratory system development | 1 |
| response to pheromone | 1 |
| cellular response to chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| protein binding | 1 |
| binding | 1 |
| extrinsic component of cytoplasmic side of plasma membrane | 1 |
| plasma membrane protein complex | 1 |
| GTPase complex | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1176 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GNG8 | BRS3 | P32247 | 510 |
| GNG8 | GNGT2 | O14610 | 507 |
| GNG8 | GNG13 | Q9P2W3 | 492 |
| GNG8 | RAET1E | Q8TD07 | 453 |
| GNG8 | OR10A6 | Q8NH74 | 412 |
| GNG8 | OR9G4 | Q8NGQ1 | 410 |
| GNG8 | GNAL | P38405 | 408 |
| GNG8 | OR2A5 | Q96R48 | 408 |
| GNG8 | ERBB2 | P04626 | 402 |
| GNG8 | GNB4 | Q9HAV0 | 400 |
| GNG8 | OR6C1 | Q96RD1 | 391 |
| GNG8 | GNB5 | O14775 | 388 |
| GNG8 | CNGA2 | Q16280 | 385 |
| GNG8 | OR56A4 | Q8NGH8 | 381 |
| GNG8 | GTSF1L | Q9H1H1 | 378 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GNG8 | GNAI1 | psi-mi:“MI:0914”(association) | 0.640 |
| GNG8 | GNB5 | psi-mi:“MI:0914”(association) | 0.640 |
| GNG8 | GNB1 | psi-mi:“MI:0914”(association) | 0.530 |
| GNG8 | GNB2 | psi-mi:“MI:0914”(association) | 0.530 |
| CXCR5 | GNB3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CXCR5 | GNG8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GNG8 | GNB3 | psi-mi:“MI:0914”(association) | 0.350 |
| GNG8 | GNAS | psi-mi:“MI:0914”(association) | 0.350 |
| GNG8 | Ntsr1 | psi-mi:“MI:0914”(association) | 0.350 |
| GNG8 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (127): GNG8 (Affinity Capture-Western), HP (Affinity Capture-MS), MPO (Affinity Capture-MS), IGLC2 (Affinity Capture-MS), TF (Affinity Capture-MS), APOB (Affinity Capture-MS), GNAS (Affinity Capture-MS), GNAI2 (Affinity Capture-MS), GNAO1 (Affinity Capture-MS), GNAQ (Affinity Capture-MS), LYZ (Affinity Capture-MS), FGG (Affinity Capture-MS), CFH (Affinity Capture-MS), CFB (Affinity Capture-MS), IGHA1 (Affinity Capture-MS)
ESM2 similar proteins: A0A804HLA8, O14610, O60262, O97564, P02698, P30671, P38040, P43425, P50150, P50151, P50153, P50154, P54406, P59768, P61952, P61953, P61954, P63077, P63078, P63210, P63211, P63212, P63213, P63214, P63215, P63216, P63217, P63218, P63219, Q28024, Q4VT26, Q5E9F0, Q5R639, Q5R7U4, Q5RBQ0, Q5REH7, Q61012, Q61016, Q61017, Q6CPB4
Diamond homologs: A0A804HLA8, O60262, P30671, P38040, P43425, P50150, P50151, P50153, P59768, P63077, P63078, P63212, P63213, P63214, P63215, P63216, P63217, P63218, P63219, Q28024, Q4VT26, Q5R639, Q5R7U4, Q5RBQ0, Q5REH7, Q61016, Q80SZ7, Q9CXP8, Q9DAS9, Q9UBI6, Q9UK08, O14610, O97564, P02698, P50154, P54406, P61952, P61953, P61954, P63210
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
105 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:46634601:T:A | donor_gain | 1.0000 |
| 19:46634621:T:TA | donor_gain | 1.0000 |
| 19:46634593:CAGCA:C | donor_loss | 0.9900 |
| 19:46634595:GCAC:G | donor_loss | 0.9900 |
| 19:46634596:CA:C | donor_loss | 0.9900 |
| 19:46634597:ACCTT:A | donor_loss | 0.9900 |
| 19:46634202:CAC:C | acceptor_gain | 0.9800 |
| 19:46634204:CCT:C | acceptor_loss | 0.9800 |
| 19:46634205:C:CC | acceptor_gain | 0.9800 |
| 19:46634599:CTT:C | donor_loss | 0.9700 |
| 19:46634200:GACAC:G | acceptor_gain | 0.9600 |
| 19:46634201:ACAC:A | acceptor_gain | 0.9600 |
| 19:46634202:CACC:C | acceptor_gain | 0.9600 |
| 19:46634203:AC:A | acceptor_gain | 0.9600 |
| 19:46634204:CC:C | acceptor_gain | 0.9600 |
| 19:46634614:GTTCA:G | donor_loss | 0.9300 |
| 19:46634615:TTCAC:T | donor_loss | 0.9300 |
| 19:46634616:TCACC:T | donor_loss | 0.9300 |
| 19:46634617:CACCT:C | donor_loss | 0.9300 |
| 19:46634618:ACCTC:A | donor_loss | 0.9300 |
| 19:46634619:C:A | donor_loss | 0.9300 |
| 19:46634620:C:T | donor_loss | 0.9300 |
| 19:46634589:G:GT | donor_gain | 0.9200 |
| 19:46634622:C:A | donor_gain | 0.9200 |
| 19:46634621:T:A | donor_loss | 0.9100 |
| 19:46634203:ACC:A | acceptor_gain | 0.9000 |
| 19:46634204:CCTGC:C | acceptor_gain | 0.9000 |
| 19:46634595:G:C | donor_gain | 0.9000 |
| 19:46634201:ACACC:A | acceptor_gain | 0.8900 |
| 19:46634202:CACCT:C | acceptor_gain | 0.8700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000142200 (19:46639323 T>A,C), RS1000747480 (19:46638042 C>G,T), RS1000961931 (19:46636951 C>A,T), RS1001158588 (19:46638285 C>T), RS1001851255 (19:46635910 G>A), RS1001967445 (19:46635312 CGCAGAG>C,CGCAGAGGCAGAG), RS1001978633 (19:46636480 C>T), RS1002321886 (19:46637935 A>G), RS1002618590 (19:46634904 G>A), RS1003104094 (19:46638997 A>C,G), RS1003167850 (19:46641006 C>A,T), RS1005210002 (19:46640858 T>C), RS1005656172 (19:46634777 C>T), RS1005774 (19:46633905 C>A), RS1005774278 (19:46635850 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004132_48 | Crohn’s disease | 4.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation | 4 |
| mercuric bromide | decreases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| sodium arsenite | affects cotreatment, decreases expression | 1 |
| entinostat | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Estradiol | affects expression | 1 |
| Tretinoin | decreases expression, affects cotreatment | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2XX | Abcam HEK293T GNG8 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.